2025 – IP Group plc

Search in site

2022 data tab

Sector

Company name

Date	Title
17 Oct 2025	Artios Pharma Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025
16 Oct 2025	Genomics Genomics launches Mystra: the world’s first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development
15 Oct 2025	Mission Therapeutics Limited Mission Therapeutics raises $13.3 million to progress first-in-class Parkinson’s disease candidate MTX325 through clinical trials
14 Oct 2025	Akamis Bio Akamis Bio Receives FDA Fast Track Designation for NG-350A for the Treatment of Mismatch Repair-Proficient Locally Advanced Rectal Cancer
14 Oct 2025	Iksuda Therapeutics Ltd Iksuda to present IKS014 Phase 1 data at ESMO
13 Oct 2025	Artios Pharma Artios to Announce First Phase 1/2a Data for DNA Polymerase Theta (Polθ) Inhibitor ART6043 in Advanced Solid Tumors in Oral Presentation at ESMO
06 Oct 2025	Monolith CoreWeave to Acquire Monolith, Expanding AI Cloud Platform into Industrial Innovation
01 Oct 2025	Accelercomm Ltd AccelerComm and Radisys Secure Funding from UK Space Agency for Next Generation 5G Satellites
29 Sep 2025	OXCCU OXCCU raises $28m in series B funding to scale sustainable aviation fuel from waste carbon
24 Sep 2025	Artios Pharma Artios Receives U.S. FDA Fast Track Designation for alnodesertib in ATM-negative Metastatic Colorectal Cancer (mCRC)
Load more112

Load more